CN1212130C - Medicine for treating psoriasis, ichthyosis and eczema - Google Patents
Medicine for treating psoriasis, ichthyosis and eczema Download PDFInfo
- Publication number
- CN1212130C CN1212130C CNB011234040A CN01123404A CN1212130C CN 1212130 C CN1212130 C CN 1212130C CN B011234040 A CNB011234040 A CN B011234040A CN 01123404 A CN01123404 A CN 01123404A CN 1212130 C CN1212130 C CN 1212130C
- Authority
- CN
- China
- Prior art keywords
- ichthyosis
- eczema
- present
- psoriasis
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a medical composition for treating psoriasis, ichthyosis and eczema. The medical medicine comprises prednisone, chlortrimeton, moroxydine, sulfur, mercury, acetic acid, baical skullcap root, golden thread, rehmannia root, shrunk bugbane and other components. The present invention can effectively treat various kinds of psoriasis, ichthyosis and eczema, and the cure rate is as high as 99%. For a plurality of cases which are not cured by perennial treatment, the present invention can reach the same effect.
Description
Invention field
The present invention relates to a kind of pharmaceutical composition for the treatment of psoriasis, ichthyosis and eczema.
Background technology
Psoriasis claims psoriasis again, and is relevant with multiple factors such as heredity, immunity, is a kind of pertinacious disease of very difficult healing.
Ichthyosis is a kind of heritability keratosis.
Eczema also is a kind of with the relevant dermatosis of multiple factor.
Since above-mentioned disease cause of disease complexity, no specific therapy medicine, and the Western medicine controlling symptoms is very fast, but recurrence easily, and Chinese medicine has Pilulae Indigo Naturalis, Xiaoyin spirit, Etretinate etc., and curative effect is comparatively slow, and cure rate is also low.The present invention is directed to the pharmaceutical composition that this has filtered out a kind for the treatment of both the principal and secondary aspects of a disease, cure rate height, treatment psoriasis, ichthyosis and eczema that relapse rate is low.
Summary of the invention
Therefore purpose of the present invention provides the medicine of a kind of effective treatment psoriasis, ichthyosis and eczema.
Medicine of the present invention is made up of following bulk drugs:
Prednisone 0.05-0.5
Chlorphenamine 0.05-0.3
Moroxydine 0.5-8
Hydrargyrum 1-7
Radix Scutellariae 10-100
Rhizoma Coptidis 10-100
Acetic acid 10-300
Radix Rehmanniae 10-100
Rhizoma Cimicifugae 5-30
Sulfur 30-80
Mercurochrome 1-10
Realgar 5-40
Mylabris 10-100
Moschus 0-2
The optimum weight proportioning of medicine of the present invention is:
Prednisone 0.15
Chlorphenamine 0.12
Moroxydine 3
Hydrargyrum 5
Radix Scutellariae 60
Rhizoma Coptidis 60
Acetic acid 100
Radix Rehmanniae 60
Rhizoma Cimicifugae 10
Sulfur 60
Mercurochrome 5
Realgar 20
Mylabris 60
Moschus 1
Wherein Radix Rehmanniae is preferably the Radix Rehmanniae.
The method for preparing medicine of the present invention comprises: the solid material component pulverize separately in the aforementioned pharmaceutical compositions is become fine powder, fully mix with the liquid charging stock component again, add then as the tallow of the 50-300 weight portion of substrate and the vaseline of 5-50 weight portion and evenly be in harmonious proportion, obtain cream drug.Optional is, before pulverizing, is placed in the porcelain jar land burial one month with Radix Scutellariae, Rhizoma Coptidis, Radix Rehmanniae, Rhizoma Cimicifugae, Realgar, Mylabris and Moschus cryogenic freezing one month with prednisone, chlorphenamine, moroxydine.
Wherein tallow can be leaf fat, Adeps Bovis seu Bubali, Adeps caprae seu ovis etc.
Carried out clinic trial with medicine of the present invention in how tame hospital, treated the various psoriasises of 2000 many cases, ichthyosis and eczema patients altogether, Therapeutic Method is that the outsourcing binder is coated with once or directly applies 2-3 time/day every day.General 10 days take effect, 20-30 days the recovery from illness, skin as before, its cure rate for the large tracts of land patient who fails to respond to any medical treatment for many years, also can reach same effect, non-relapse after healing up to 99%.But be noted that be coated with outside the large tracts of land use once to surpass 1/3rd of body surface area, form interior-heat in order to avoid stop up pore.
Specific embodiment
Below in conjunction with embodiment the present invention is described.
Embodiment 1
Prednisone 1.5g
Chlorphenamine 1.2g
Moroxydine 30g
Hydrargyrum 50g
Radix Scutellariae 600g
Rhizoma Coptidis 600g
Acetic acid 1000g
Radix Rehmanniae 600g
Rhizoma Cimicifugae 100g
Sulfur 600g
Mercurochrome 50g
Realgar 200g
Mylabris 600g
Moschus 10g
Above-mentioned solid material component pulverize separately is become fine powder, fully mix with the liquid charging stock component, the 1500g Adeps Sus domestica and the 250g vaseline that add then as substrate evenly are in harmonious proportion, and obtain cream drug.
Embodiment 2
Prednisone 1.5g
Chlorphenamine 1.2g
Moroxydine 30g
Hydrargyrum 50g
Radix Scutellariae 600g
Rhizoma Coptidis 600g
Acetic acid 1000g
Radix Rehmanniae 600g
Rhizoma Cimicifugae 100g
Sulfur 600g
Mercurochrome 50g
Realgar 200g
Mylabris 600g
Above-mentioned solid material component pulverize separately is become fine powder, mix with the liquid charging stock component, the 1500g Adeps Sus domestica and the 250g vaseline that add then as substrate evenly are in harmonious proportion, and obtain cream drug.
Claims (2)
1, a kind of pharmaceutical composition for the treatment of psoriasis, ichthyosis and eczema, form by following bulk drugs:
Prednisone 0.05-0.5
Chlorphenamine 0.05-0.3
Moroxydine 0.5-8
Hydrargyrum 1-7
Radix Scutellariae 10-100
Rhizoma Coptidis 10-100
Acetic acid 10-300
Radix Rehmanniae 10-100
Rhizoma Cimicifugae 5-30
Sulfur 30-80
Mercurochrome 1-10
Realgar 5-40
Mylabris 10-100
Moschus 0-2
2, the method for compositions of preparation claim 1, it comprises: the solid material component pulverize separately in the described pharmaceutical composition is become fine powder, fully mix with the liquid charging stock component again, add then as the tallow of the 50-300 weight portion of substrate and the vaseline of 5-50 weight portion and evenly be in harmonious proportion, obtain cream drug.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011234040A CN1212130C (en) | 2001-07-19 | 2001-07-19 | Medicine for treating psoriasis, ichthyosis and eczema |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011234040A CN1212130C (en) | 2001-07-19 | 2001-07-19 | Medicine for treating psoriasis, ichthyosis and eczema |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1332011A CN1332011A (en) | 2002-01-23 |
CN1212130C true CN1212130C (en) | 2005-07-27 |
Family
ID=4665032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011234040A Expired - Fee Related CN1212130C (en) | 2001-07-19 | 2001-07-19 | Medicine for treating psoriasis, ichthyosis and eczema |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1212130C (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1298347C (en) * | 2005-03-23 | 2007-02-07 | 刘朝辉 | Paste preparation for treating oxide lichen and its preparation technology |
CN100400077C (en) * | 2005-06-08 | 2008-07-09 | 孙绪忠 | An externally applied medicine for treating alphos |
CN102166285B (en) * | 2011-04-20 | 2013-05-01 | 姜莉蔚 | Umbilical plaster for treating allergic skin itching and psoriasis and preparation method thereof |
CN102973674B (en) * | 2012-11-22 | 2014-08-13 | 张继成 | Eczema eliminating capsule |
-
2001
- 2001-07-19 CN CNB011234040A patent/CN1212130C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1332011A (en) | 2002-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100350951C (en) | External-applied medicine for treating burn, valnus and local tumor inflammation | |
CN1146358A (en) | Shengkang injection solution (for nephrosis) and preparation technology | |
CN1212130C (en) | Medicine for treating psoriasis, ichthyosis and eczema | |
CN1927240A (en) | Traditional Chinese medicine mask composition for depigmenting | |
CN101049337A (en) | Medication for curing furuncle, sore, and carbuncle, and preparation method | |
CN1060657C (en) | Nourishing medicine for preventing and curing toxic and side effect after tumor radiotherapy and chemotherapy and preparation method | |
CN1196491C (en) | Ointment for healing tranumatic injury fast | |
CN1698803A (en) | Compound notoginseng injection and its preparation process | |
CN1163251C (en) | Weishukang for treating gastrosis | |
CN1895424A (en) | Externally-applied medicinal liquid for treating dermatosis | |
CN1259924C (en) | Chinese medicine for ftracture and preparation thereof | |
CN1054541C (en) | Traditional Chinese medicine for treating mastosis | |
CN1102335A (en) | Health-care carambola oral liquid | |
CN1051468C (en) | Capsule for curing rheumatism | |
CN1059831C (en) | Chinese medicinal preparation for treating leukemia | |
CN1413656A (en) | Weinakang for treating ischemic cerebrovascular disease and senile dementia and its preparation method | |
CN1371722A (en) | Soft-extract for removing channel obstruction and relieving pain | |
CN1265806C (en) | Medicinal composition for treating rheumatism | |
CN1251711C (en) | External use anti-inflammatory and myogenic medicine of chinese medicine and its preparing method | |
CN1286492C (en) | Traditional Chinese medicinal plaster | |
CN1857553A (en) | Wound healing medicine | |
CN100350932C (en) | Medicine for non operation treating nasitis and pharyngolaryngitis | |
CN1141113C (en) | Chinese patent medicine for curing peptic ulcer | |
CN1054991C (en) | Inhalation for cough and asthma and its preparing method | |
CN1235599C (en) | Arsenic compound recipe for treating tuberculosis and dermatopathy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |